ChromaDex Corporation carries a market capitalization of 611.90M, placing it among publicly traded companies globally. Its enterprise value stands at 476.40M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 611.90M |
| Enterprise Value | 476.40M |
ChromaDex Corporation currently has 78.43M shares outstanding.
| Shares Outstanding | 78.43M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
ChromaDex Corporation trades at a trailing price-to-earnings ratio of 37.46. The price-to-sales ratio is 4.90, and the price-to-book ratio stands at -2.99.
| PE Ratio | 37.46 |
| PS Ratio | 4.90 |
| PB Ratio | -2.99 |
| P/TBV Ratio | 9.60 |
| P/FCF Ratio | 27.65 |
| P/OCF Ratio | 26.82 |
On an enterprise value basis, ChromaDex Corporation trades at an EV/EBITDA multiple of 32.43 and an EV/FCF ratio of 24.00. The EV/Sales ratio of 4.41 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 36.01 provides insight into valuation relative to core operating earnings.
| EV / Sales | 4.41 |
| EV / EBITDA | 32.43 |
| EV / EBIT | 36.01 |
| EV / FCF | 24.00 |
ChromaDex Corporation maintains a current ratio of 3.66, meaning it holds 3.7x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 3.66 |
| Quick Ratio | 3.00 |
| Debt / Equity | 6.37 |
| Debt / EBITDA | 0.24 |
| Interest Coverage | N/A |
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | 20.83 |
| Return on Invested Capital (ROIC) | 28.78 |
| Return on Capital Employed (ROCE) | -7.82 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 3.42 |
Over the trailing twelve months, ChromaDex Corporation has paid 168,000.00 in income taxes, reflecting an effective tax rate of 1.15.
| Income Tax | 168,000.00 |
| Effective Tax Rate | 1.15 |
ChromaDex Corporation's stock has gained approximately 98.23678% over the past 52 weeks. The 50-day moving average sits at 6.34, while the 200-day moving average is 4.81.
| Beta (5Y) | N/A |
| 52-Week Price Change | 98.23678% |
| 50-Day Moving Average | 6.34 |
| 200-Day Moving Average | 4.81 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, ChromaDex Corporation generated 107.93M in revenue and converted that into 14.11M in net income, yielding earnings per share of 0.18. EBITDA reached 14.69M, while operating income came in at 13.23M.
| Revenue | 107.93M |
| Gross Profit | 67.46M |
| Operating Income | 13.23M |
| Pretax Income | 14.58M |
| Net Income | 14.11M |
| EBITDA | 14.69M |
| EBIT | 13.23M |
| Earnings Per Share (EPS) | 0.18 |
ChromaDex Corporation holds 55.46M in cash and equivalents against 3.52M in total debt, resulting in a net debt position of -55.46M. Total book value stands at -176.77M, with working capital of 55.38M providing operational flexibility.
| Cash & Cash Equivalents | 55.46M |
| Total Debt | 3.52M |
| Net Debt | -55.46M |
| Equity (Book Value) | -176.77M |
| Book Value Per Share | -2.31 |
| Working Capital | 55.38M |
ChromaDex Corporation produced 19.70M in operating cash flow over the past twelve months. After subtracting -154,000.00 in capital expenditures, free cash flow totaled 19.54M - equivalent to 0.26 per share.
| Operating Cash Flow | 19.70M |
| Capital Expenditures | -154,000.00 |
| Free Cash Flow | 19.54M |
| FCF Per Share | 0.26 |
ChromaDex Corporation operates with a gross margin of 62.51, reflecting its pricing power and cost economics. The operating margin of 12.26 and net profit margin of 13.07 provide insight into operational efficiency.
| Gross Margin | 62.51 |
| Operating Margin | 12.26 |
| Pretax Margin | 13.51 |
| Profit Margin | 13.07 |
| EBITDA Margin | 13.61 |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -1.61 |
| FCF Yield | 3.62 |
ChromaDex Corporation's most recent stock split took place on April 13, 2016 with a 3:1 split ratio.
| Last Split Date | 4/13/2016 |
| Split Ratio | 3:1 |
ChromaDex Corporation posts an Altman Z-Score of 11.83, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 11.83 |